Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination
Dragan Primorac, Petar Brlek, Vid Matišić, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 442-442
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Adaptive Immune Responses and Immunity to SARS-CoV-2
Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Immunological considerations for COVID-19: Vaccines and other protective strategies
Dragan Primorac, Kristijan Vrdoljak, Tomabu Adjobimey, et al.
Elsevier eBooks (2025), pp. 175-190
Closed Access
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers
Alexandra Lochmanová, Jan Martínek, Hana Tomášková, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 637-637
Open Access | Times Cited: 7
Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice
Ziyu Wen, Yue Yuan, Yangguo Zhao, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1316-1316
Open Access | Times Cited: 7
Comparison of Four T-cell Assays and Two Binding Antibody Assays in SARS-CoV-2 Vaccinees With or Without Omicron Breakthrough Infection
Yeon Ju Seo, Inseong Oh, Minjeong Nam, et al.
Annals of Laboratory Medicine (2023) Vol. 43, Iss. 6, pp. 596-604
Open Access | Times Cited: 7
Importance of Cellular Immunity and IFN-γ Concentration in Preventing SARS-CoV-2 Infection and Reinfection: A Cohort Study
Dragan Primorac, Petar Brlek, Eduard Pavelić, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 792-792
Open Access | Times Cited: 6
Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
Natalia Syrimi, Flora Sourri, Maria-Christina Giannakopoulou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3172-3172
Open Access | Times Cited: 6
Inflammation and Immune Reactions in the Fetus as a Response to COVID-19 in the Mother
N. R. Gashimova, Liudmila L. Pankratyeva, В. О. Бицадзе, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4256-4256
Open Access | Times Cited: 6
STING and TLR9 agonists synergistically enhance the immunogenicity of SARS-CoV-2 subunit vaccine
Yang Li, Ziwei Chen, Xinyi Lu, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13322-13334
Closed Access | Times Cited: 6
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
Lisa Blixt, Yu Gao, David Wullimann, et al.
Blood (2022) Vol. 140, Iss. 22, pp. 2403-2407
Open Access | Times Cited: 10
A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients
M. Cecilia Poli, Cecilia Vial, Emma Rey-Jurado, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1012-1012
Open Access | Times Cited: 5
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)
Sarinya Boongird, Chavachol Setthaudom, Rungthiwa Kitpermkiat, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1064-1064
Open Access | Times Cited: 7
Determinants of protection against SARS‐CoV‐2 Omicron BA.1 and Delta infections in fully vaccinated outpatients
Álvaro Roy, Carla Saade, Laurence Josset, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 3
SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1276-1276
Open Access | Times Cited: 2
Enzymatic approaches against SARS-CoV-2 infection with an emphasis on the telomere-associated enzymes
Alireza Valdiani, Hamideh Ofoghi
Biotechnology Letters (2023) Vol. 45, Iss. 3, pp. 333-345
Open Access | Times Cited: 2
Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers
Jesús Mateos‐Nozal, Mario Rodríguez-Domínguez, Jesús San Román, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 186-186
Open Access
Difference of Omicron variant infection and influence factors between people with and without HIV infection
Jianhui Yang, Esben Strodl, Dandan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination
Faustine Montmaneix-Engels, Chloé Dimeglio, Laeticia Staes, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29116-e29116
Open Access
Interferon-γ Release Assay in the Assessment of Cellular Immunity—A Single-Centre Experience with mRNA SARS-CoV-2 Vaccine in Patients with Juvenile Idiopathic Arthritis
Katarzyna Kapten, Krzysztof Orczyk, Anna Maeser, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2523-2523
Open Access
Genetic, Clinical, Epidemiological, and Immunological Profiling of IgG Response Duration after SARS-CoV-2 Infection
Flávia Póvoa da Costa, Kevin Matheus Lima de Sarges, Rosilene da Silva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8740-8740
Open Access
Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination
Lina Souan, Hikmat Abdel‐Razeq, Maher A. Sughayer
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 10, pp. 11124-11135
Open Access
Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers
Hyeyoung Lee, Geon Young Ko, Ji‐Hyun Lee, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1350-1350
Open Access
The impact of COVID-19 on sustainable development
Dragan Primorac, Richard J. Roberts
Croatian Medical Journal (2022) Vol. 63, Iss. 3, pp. 213-220
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top